4.4 Article

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Medicine, General & Internal

Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons From Previous Epidemics

David L. Swerdlow et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 and the cardiovascular system

Ying-Ying Zheng et al.

NATURE REVIEWS CARDIOLOGY (2020)

Article Infectious Diseases

Transmission potential and severity of COVID-19 in South Korea

Eunha Shim et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Editorial Material Medicine, General & Internal

Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy

Graziano Onder et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Public, Environmental & Occupational Health

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Alfonso J. Rodriguez-Morales et al.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)

Article Medicine, General & Internal

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Tao Chen et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Article Infectious Diseases

Early dynamics of transmission and control of COVID-19: a mathematical modelling study

Adam J. Kucharski et al.

LANCET INFECTIOUS DISEASES (2020)

Article Public, Environmental & Occupational Health

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Cardiac & Cardiovascular Systems

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Tao Guo et al.

JAMA CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

Shaobo Shi et al.

JAMA CARDIOLOGY (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

Clinical Characteristics of Covid-19 in New York City

Parag Goyal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Compassionate Use of Remdesivir for Patients with Severe Covid-19

J. Grein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Respiratory System

Prognostic value of NT-proBNP in patients with severe COVID-19

Lei Gao et al.

RESPIRATORY RESEARCH (2020)

Letter Rheumatology

Canakinumab in a subgroup of patients with COVID-19

Claudio Ucciferri et al.

LANCET RHEUMATOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Fourth Universal Definition of Myocardial Infarction (2018)

Kristian Thygesen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Medicine, General & Internal

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Pharmacology & Pharmacy

Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody

Abhijit Chakraborty et al.

CLINICAL PHARMACOKINETICS (2012)

Article Medicine, General & Internal

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

Helen J. Lachmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Pharmacology & Pharmacy

ACE2: from vasopeptidase to SARS virus receptor

AJ Turner et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2004)

Article Cardiac & Cardiovascular Systems

Inflammation and atherosclerosis

P Libby et al.

CIRCULATION (2002)